Xometry, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Xometry director Randolph Altschuler sold $1.63M in shares on Oct 1-2, 2026, via pre-planned trades. XMTR stock is near its 52-week high, up 99% YoY, but shows negative free cash flow. Q2 2026 earnings beat estimates, with revenue up 41% YoY. Analysts raised price targets to $120 with Buy ratings.
Xometry's CTO sold 1,866 shares worth $192,725 at prices between $101.41 and $105.76, under a 10b5-1 plan. The company's stock is near a 52-week high, up 99% year-over-year. Xometry's Q2 2026 earnings beat estimates, with revenue up 41%. Analysts raised price targets to $120, maintaining buy ratings.
Xometry CEO Sanjeev Sahni sold 1,112 shares for $114,851 under a 10b5-1 plan to cover tax obligations. He holds 179,791 shares. XMTR trades near 52-week high, up 99% YoY. Q2 2026 earnings beat estimates: $0.16 EPS on $229.3M revenue, up 41% YoY. Analysts raised price targets to $120.
Over the past 7 days, AlphAI's AI scored 4 news stories mentioning XMTR (Xometry, Inc.). Coverage has skewed bearish: 0 bullish, 3 neutral, and 1 bearish.
Recent XMTR coverage spans financial news, insider activity and earnings.
In the last 30 days, XMTR insiders filed 26 SEC Form 4 transactions — no purchases and 26 sales ($2.1M). The most active reporter was Altschuler Randolph with 11 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
Insider selling may signal concerns and could weigh on the stock.
The insider sale may create modest selling pressure on XMTR.
Small insider sale may cause modest short-term selling pressure.
The insider sale suggests potential downside pressure as a key insider reduces their stake.
The insider sale may signal reduced confidence and could pressure the stock lower.
AlphAI scores every news story that mentions XMTR with an AI model for sentiment and relevance, and aggregates insider trades from Xometry, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Xometry director Randolph Altschuler sold $1.63M in shares on Oct 1-2, 2026, via pre-planned trades. XMTR stock is near its 52-week high, up 99% YoY, but shows negative free cash flow. Q2 2026 earnings beat estimates, with revenue up 41% YoY. Analysts raised price targets to $120 with Buy ratings.
2 min readXometry's CTO sold 1,866 shares worth $192,725 at prices between $101.41 and $105.76, under a 10b5-1 plan. The company's stock is near a 52-week high, up 99% year-over-year. Xometry's Q2 2026 earnings beat estimates, with revenue up 41%. Analysts raised price targets to $120, maintaining buy ratings.
1 min readXometry CEO Sanjeev Sahni sold 1,112 shares for $114,851 under a 10b5-1 plan to cover tax obligations. He holds 179,791 shares. XMTR trades near 52-week high, up 99% YoY. Q2 2026 earnings beat estimates: $0.16 EPS on $229.3M revenue, up 41% YoY. Analysts raised price targets to $120.
2 min readAltschuler Randolph sold 5,721 shares of Xometry, Inc. (XMTR) at an average of $103.32 ($101.39–$106.36, $0.59M total) across 6 trades on 2026-10-02 under a Rule 10b5-1 trading plan.
1 min readAltschuler Randolph sold 10,000 indirectly-held shares of Xometry, Inc. (XMTR) at an average of $104.04 ($102.55–$106.19, $1.04M total) across 5 trades on 2026-10-01 under a Rule 10b5-1 trading plan.
1 min readXometry officer Sanjeev Singh Sahni plans to sell 1,112 shares worth $116,570.96 on October 2, 2026, according to a regulatory filing. Sahni previously sold 1,500 shares each in August and September 2026, totaling $263,116.80. The shares were acquired through restricted stock units.
1 min readXometry (XMTR) stock has surged 144% in six months, driven by strong Q2 earnings and a Siemens partnership. Q2 revenue was $229.28M, up 41% YoY, beating estimates. Analysts have raised targets to $110, 14% above current price. Insiders have sold $3.46M in stock since July.
3 min readSix Montgomery County companies raised over $566 million in Q3. Forbright (Nasdaq) completed an IPO, raising $142.2 million. Xometry (Nasdaq) announced a $225 million secondary offering. RegenxBio (Nasdaq) raised $90.04 million in a public offering. Georgiamune secured $92.69 million in venture funding. Arculus Solutions raised $1.95 million in Seed-1 funding. Jesse & Ben raised $15 million in Series A funding.
3 min readXometry's stock rose due to an expanded partnership with TradeCentric and the launch of an AI-driven Workcenter, following record Q2 results. The company aims to strengthen its digital manufacturing platform, but remains unprofitable with debt.
2 min readXometry Inc. (NASDAQ:XMTR) expanded its partnership with TradeCentric, adding Purchase Order Automation and Invoice Automation to its eProcurement systems. The integration supports over 220 solutions, including Coupa and SAP Ariba, aiming to streamline purchasing and invoicing processes. Xometry's CEO highlighted the importance of digital infrastructure for custom manufacturing. The service is available in the U.S., with plans for international expansion.
2 min read
